Design of Mutation-resistant HIV Protease Inhibitors with the Substrate Envelope Hypothesis.
Chellappan, S., Kiran Kumar Reddy, G.S., Ali, A., Nalam, M.N., Anjum, S.G., Cao, H., Kairys, V., Fernandes, M.X., Altman, M.D., Tidor, B., Rana, T.M., Schiffer, C.A., Gilson, M.K.(2007) Chem Biol Drug Des 69: 298-313
- PubMed: 17539822 
- DOI: 10.1111/j.1747-0285.2007.00514.x
- Primary Citation of Related Structures:  
2PSU, 2PSV - PubMed Abstract: 
There is a clinical need for HIV protease inhibitors that can evade resistance mutations. One possible approach to designing such inhibitors relies upon the crystallographic observation that the substrates of HIV protease occupy a rather constant region within the binding site ...